The veterinary point-of-care diagnostics market stood at USD 2.2 billion in 2025 and is forecast to reach USD 5.76 billion by 2035, growing at a compound annual rate of 10.1%. The single strongest catalyst is the convergence of rising pet ownership globally with intensifying pressure on livestock producers to detect disease rapidly and minimize productivity loss. These dual drivers are reshaping how veterinary practices operate, moving diagnostic capability from centralized labs into clinics and farm sites where immediate results inform faster clinical choices.
What is driving growth
Immediate on-site diagnosis has become operationally essential in veterinary practice. Practitioners depend on PoC solutions to bypass laboratory turnaround delays, enabling faster treatment initiation and reducing animal suffering during diagnostic intervals. Companion animal ownership continues to expand globally, raising demand for accessible diagnostics in private clinics, while livestock producers operate under tightening disease-control protocols where rapid detection is prerequisite for herd health and regulatory compliance. Product innovation in analyzer design, test throughput and connectivity has steadily raised the clinical credibility of PoC results, expanding veterinary confidence in decentralized testing across an expanding menu of conditions and animal species.
Restraints and challenges
Historical performance gaps between PoC and laboratory testing persist in certain clinical domains, particularly where diagnostic sensitivity or specificity is critical. Complex disease scenarios sometimes demand confirmatory lab testing, limiting PoC deployment in high-stakes diagnostic pathways and slowing adoption among practitioners who prioritize diagnostic certainty over speed. Supply-chain instability and cost volatility for raw materials and components add manufacturing friction, while fragmented regulatory standards across regions complicate product approval timelines and operational compliance, collectively slowing market expansion and raising barriers for smaller innovators.
Market structure reveals clear segment leaders. Consumables, test kits, cartridges, reagent packs and strips, command 88.0% of the product mix in 2025, reflecting the volume and frequency of routine PoC testing across all veterinary settings. Immunodiagnostics account for 84.7% of the technology share, as lateral flow and ELISA-based rapid tests have proven most practical for field deployment and are widely trusted by practitioners across infectious disease and chronic condition detection.
Companion animals represent 72.5% of the animal-type segment, driven by pet owners’ willingness to fund diagnostic speed and early detection, though livestock diagnostics remain a substantial secondary market. Geographic demand patterns diverge meaningfully across regions. Asia Pacific is accelerating fastest at 9.0% CAGR through the forecast decade, propelled by expanding pet populations in urban centers and modernizing livestock systems across the region.
Companies profiled
- IDEXX Laboratories Inc
- Zoetis Services LLC
- SKYLA CORPORATION
- Fluxergy Inc
- Forecast
- CAGR
For complete market sizing, forecasts, and competitive intelligence, read the full Veterinary PoC Diagnostics Market — covering growth drivers, regional analysis, and leading company profiles through 2033.